(Q44828700)

6 December 2017

title

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. (English)

1 reference

Idiopathic pneumonia syndrome

6 December 2017

1 reference

1 reference

16

D L Porter

1 reference

6 December 2017

15

E A Stadtmauer

1 reference

6 December 2017

6

E O Hexner

1 reference

6 December 2017

7

A Loren

1 reference

6 December 2017

8

S M Luger

1 reference

6 December 2017

R Tizon

1

1 reference

6 December 2017

N Frey

2

1 reference

6 December 2017

D F Heitjan

3

1 reference

6 December 2017

K S Tan

4

1 reference

6 December 2017

S C Goldstein

5

1 reference

6 December 2017

R Reshef

9

1 reference

6 December 2017

D Tsai

10

1 reference

6 December 2017

D Vogl

11

1 reference

6 December 2017

J Davis

12

1 reference

6 December 2017

M Vozniak

13

1 reference

6 December 2017

B Fuchs

14

1 reference

6 December 2017

language of work or name

English

0 references

publication date

6 February 2012

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

47

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

1332-1337

1 reference

NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

TUMOR NECROSIS FACTOR-?? NEUTRALIZATION REDUCES LUNG INJURY AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Noninfectious pneumonitis after blood and marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

The lung as a target organ of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice. Role of pretransplant radiation conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.260

7 January 2021

Identifiers

DOI

10.1038/BMT.2011.260

1 reference

Dimensions Publication ID

6 December 2017

1025483575

0 references

1 reference